Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001213900-26-059665
Filing Date
2026-05-20
Accepted
2026-05-20 17:29:17
Documents
20

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0291624-f3_purple.htm F-3 532252
2 OPINION OF LAW OFFICE OF FISCHER (FBC & CO.) ea029162401ex5-1.htm EX-5.1 18700
3 OPINION OF HAYNES AND BOONE LLP, U.S. LEGAL COUNSEL TO THE REGISTRANT ea029162401ex5-2.htm EX-5.2 9958
4 CONSENT OF SOMEKH CHAIKIN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, A MEMB ea029162401ex23-3.htm EX-23.3 3157
5 FILING FEE TABLE ea029162401ex-fee.htm   iXBRL EX-FILING FEES 59985
6 GRAPHIC ea029162401_img1.jpg GRAPHIC 4704
7 GRAPHIC ea029162401_img2.jpg GRAPHIC 4704
8 GRAPHIC ea029162401_img3.jpg GRAPHIC 4704
9 GRAPHIC ea029162401_ex5-1img1.jpg GRAPHIC 24522
10 GRAPHIC ea029162401_ex5-2img1.jpg GRAPHIC 2750
11 GRAPHIC ea029162401_ex5-2img2.jpg GRAPHIC 1343
  Complete submission text file 0001213900-26-059665.txt   874719

Data Files

Seq Description Document Type Size
23 EXTRACTED XBRL INSTANCE DOCUMENT ea029162401ex-fee_htm.xml XML 21682
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-296088 | Film No.: 261005205
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)